Inventor · disambiguated record
Jean-Paul Briand
Also filed as: BRIAND JEAN-PAUL · SCHAFFNER ARNAUD-PIERRE · SEMETEY VINCENT
21 granted patents·8 pending applications·148 citations·filing 1986–2017
94Inventor score
Files withCENTRE NAT RECH SCIENT9BIOMERIEUX SA3IMMUPHARMA FRANCE SA2MULLER SYLVIANE2BRIAND JEAN PAUL1
Top patents by PatentIndex Score
29 records- 0189US4748002ASemi-automatic, solid-phase peptide multi-synthesizer and process for the production of synthetic peptides by the use of the multi-synthesizerCENTRE NAT RECH SCIENT·Filed 1986·Granted May 31, 1988·68 cites·9 claims
- 0284US7691807B2Hybrid oligomers, their preparation process and pharmaceutical compositions containing themCENTRE NAT RECH SCIENT·Filed 2006·Granted Apr 6, 2010·7 cites·28 claims
- 0384US7186739B2Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureasIMMUPHARMA FRANCE SA·Filed 2005·Granted Mar 6, 2007·7 cites·5 claims
- 0478US7186828B2Cyclic urea compounds and preparation thereofIMMUPHARMA FRANCE SA·Filed 2001·Granted Mar 6, 2007·13 cites·3 claims
- 0577US8173767B2Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIVHOVANESSIAN ARA·Filed 2008·Granted May 8, 2012·2 cites·10 claims
- 0677US7060845B2Stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureasCENTRE NAT RECH SCIENT·Filed 2001·Granted Jun 13, 2006·14 cites·13 claims
- 0776US8138145B2Hybrid oligomers, their preparation process and pharmaceutical compositions containing themVIOLETTE AUDE·Filed 2010·Granted Mar 20, 2012·4 cites·9 claims
- 0872US8497349B2Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammationCOURTY JOSE·Filed 2007·Granted Jul 30, 2013·3 cites·11 claims
- 0972US7364744B2Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIVPASTEUR INSTITUT·Filed 2004·Granted Apr 29, 2008·6 cites·8 claims
- 1070US7872098B1Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologiesCENTRE NAT RECH SCIENT·Filed 2002·Granted Jan 18, 2011·4 cites·5 claims
- 1168US10213482B2Methods of treating chronic inflammatory diseasesCENTRE NAT RECH SCIENT·Filed 2015·Granted Feb 26, 2019·1 cites·16 claims
- 1264US8475800B2Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologiesMULLER SYLVIANE·Filed 2010·Granted Jul 2, 2013·1 cites·8 claims
- 1360US7122193B1Retro peptides, antibodies thereto and their uses for vaccination and in vitro diagnosisBIOMERIEUX SA·Filed 2000·Granted Oct 17, 2006·1 cites·14 claims
- 1457US9254309B2Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammationCENTRE NAT RECH SCIENT·Filed 2013·Granted Feb 9, 2016·0 cites·20 claims
- 1554US2014004136A1Phosphorylated derivatives of a u1-70k peptide and their use in the treatment of autoimmune pathologiesCENTRE NAT RECH SCIENT·Filed 2013·Application pending·0 cites
- 1654US2004265300A1Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)Filed 2003·Application pending·0 cites
- 1753US9657072B2Modified peptides and their use for treating autoimmune diseasesCENTRE NAT DE LA RECHERECHE SCIENT·Filed 2014·Granted May 23, 2017·0 cites·11 claims
- 1852US2010047333A1Modified Peptides and Their Use for the Treatment of Autoimmune DiseasesMULLER SYLVIANE·Filed 2009·Application pending·0 cites
- 1951US2004002457A1Inhibition of virus anchorage by RGG domain of a cell surface-expressed protein, polynucleotide coding for said RGG domain, therapeutic uses thereof by inhibition of microorganism or protein ligand binding to the cell-surface-expressed proteinFiled 2003·Application pending·0 cites
- 2050US6455244B1Methods for the detection of antibodies associated with autoimmune disorders and infectious agents employing immunoretroid peptides derived from antigens associated with said disorders and agentsBIOMERIEUX SA·Filed 1995·Granted Sep 24, 2002·12 cites·7 claims
- 2150US2003077826A1Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)Filed 2002·Application pending·0 cites
- 2247US2016200783A1Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammationCENTRE NAT RECH SCIENT·Filed 2016·Application pending·0 cites
- 2346US7691899B2Urea oligomers, the preparation method thereof and pharmaceutical composition containing sameCENTRE NAT RECH SCIENT·Filed 2002·Granted Apr 6, 2010·0 cites·16 claims
- 2446US2017226167A1Modified peptides and their use for treating autoimmune diseasesCENTRE NAT DE LA RACHERCHE SCIENT (CNRS)·Filed 2017·Application pending·0 cites
- 2544US8071640B2Urea oligomers, their preparation process and pharmaceutical compositions containing themGUICHARD GILLES FRANCOIS ROGER·Filed 2010·Granted Dec 6, 2011·0 cites·13 claims
- 2643US2002076693A1Novel cell surface receptor for HIV retroviruses, therapeutic and diagnostic usesINST PASTEUR AND CT NAT DE LA·Filed 2001·Application pending·0 cites
- 2739US9243030B2Optically pure compounds for improved therapeutic efficiencyBRIAND JEAN PAUL·Filed 2008·Granted Jan 26, 2016·0 cites·22 claims
- 2832US7199215B1Pseudopeptide, synthesis method, reagent and applicationsBIOMERIEUX SA·Filed 2000·Granted Apr 3, 2007·0 cites·14 claims
- 2931US5407833APeptides of the SM-D antigen and their use for diagnosis of systemic lupus erythematosusPASTEUR SANOFI DIAGNOSTICS·Filed 1991·Granted Apr 18, 1995·5 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Jean-Paul Briand files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →